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Title: Health System Trials  
Pragmatic randomised trials aim to provide evidence to support decisions by stakeholders in 
healthcare systems (patients, clinicians, policy makers). The typical pragmatic trial recruits a group of 
participants who then provide data for the trial using purpose built data collection systems.  Then at 
the end of the trial – all is disbanded.  This approach is costly and frequently fails to recruit 
sufficiently large or representative samples. 
Since the advent of electronic data, pragmatic trials are increasingly using routine health data 
collected from administrative, clinical and patient sources. A new group of trial designs have 
emerged which we describe as ‘Health System Trials’. These include Registry-based Randomised 
Controlled Trials (RRCTs), Electronic Health Record (EHR) Trials, Administrative Data (AD) Trials and 
Trials within Cohorts (TwiCs).  These four designs purposefully utilise existing and/or newly created 
health system data structures for one or more trial activities:  identifying potential trial participants, 
recruitment, randomisation, process and outcome data collection, etc. The process of informed 
consent is often spread out (staged) as occurs in routine healthcare especially with TwiCs designs. 
By utilising populations within health systems and the data that derives from their healthcare 
encounters, these trials efficiently recruit large representative populations and obtain short and long 
term outcomes. These designs reduce the effort and cost of trials whilst improving the applicability 
of the trial results for decision makers in health systems. 
We discuss the opportunities for these types of trial designs to be integrated within health systems, 
enabling the continuous generation of knowledge that is an essential feature of learning health 
systems. 
CONSORT Reporting guidelines for Trials Using Cohorts and Routine Health Data are currently being 
developed. Drawing on development work for these guidelines we describe real world examples of 
‘Health System Trials’ including examples of nascent vertical (disease focussed) and horizontal (e.g. 
practice based) learning health systems.  
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